{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-031463","form_type":"8-K","ticker":"CING","cik":"0001862150","company_name":"Cingulate Inc.","filed_at":"2024-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.996540+00:00","generated_at":"2026-05-31T09:50:35.519845+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Cingulate Q2 net loss narrows to $3.2M; FDA clears NDA filing for ADHD drug CTx-1301","bullets":["Net loss of $3.2M in Q2 2024 vs $6.6M in Q2 2023; R&D expenses fell to $1.9M from $4.5M YoY.","Cash and equivalents $0.4M at June 30; received $1.6M net proceeds from warrant inducement closed July 1.","FDA confirmed remaining clinical requirements; NDA submission for CTx-1301 targeted for first half 2025.","Completed 1-for-12 reverse stock split on Aug 9 to regain compliance with Nasdaq $1.00 bid price rule.","Commissioned payer study (10 payers, 121M lives) found CTx-1301 likely to gain coverage; licensing discussions ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-031463","json":"https://secwatch.observer/filing/0001493152-24-031463.json","markdown":"https://secwatch.observer/filing/0001493152-24-031463.md","text":"https://secwatch.observer/filing/0001493152-24-031463.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224031463/0001493152-24-031463-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1862150/000149315224031463/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:50:35.519845+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}